Deerfield Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-1,172,943
| Closed | -$40.1M | – | 128 |
|
|
2021
Q4 | $40.1M | Sell |
1,172,943
-221,057
| -16% | -$7.56M | 0.84% | 37 |
|
|
2021
Q3 | $24.7M | Buy |
1,394,000
+31,210
| +2% | +$553K | 0.48% | 58 |
|
|
2021
Q2 | $61.2M | Buy |
1,362,790
+104,000
| +8% | +$4.67M | 1.09% | 21 |
|
|
2021
Q1 | $32.6M | Sell |
1,258,790
-121,181
| -9% | -$3.14M | 0.69% | 48 |
|
|
2020
Q4 | $27.8M | Buy |
1,379,971
+200,000
| +17% | +$4.03M | 0.55% | 59 |
|
|
2020
Q3 | $23.1M | Buy |
1,179,971
+166,476
| +16% | +$3.25M | 0.56% | 61 |
|
|
2020
Q2 | $17.9M | Buy |
+1,013,495
| New | +$17.9M | 0.52% | 61 |
|
|
2018
Q1 | – | Sell |
-225,000
| Closed | -$4.68M | – | 120 |
|
|
2017
Q4 | $4.68M | Buy |
+225,000
| New | +$4.68M | 0.18% | 82 |
|